Disreflexia recurrente a los 20 años de una derivación vesical tipo Bricker / Recurrent dysreflexia 20 years after a Bricker's urinary bypass

La disreflexia autónoma es una emergencia médica que se desencadena por una estimulación nociceptiva de origen, generalmente, urinario. Es frecuente en los lesionados medulares a nivel o por encima de T6. Uno de los objetivos en el manejo de la vejiga neurógena consiste en preservar la función renal y de las vías urinarias, prevenir complicaciones y procurar la continencia. La necesidad de conseguir un vaciado vesical a baja presión sin depender de un catéter vesical permanente es conocida desde hace años. La ureteroileostomía fue descrita por Bricker en 1950 y se ha utilizado en múltiples ocasiones. Presentamos el caso de un paciente con tetraplejia C6 ASIA A que a los 20 años de la realización de una derivación urinaria tipo Bricker sufre crisis repetidas de disreflexia debidas a acúmulos de detritus y coágulos en la vejiga excluida, obligando a la realización de una cistectomía radical para resolución del problema (AU)

Autonomic dysreflexia is a medical emergency that is triggered by nociceptive stimulation that generally has a urinary origin. It is common in those having spinal injuries at or above T6. One of the objectives in the management of neurogenic bladder is to preserve renal and urinary tract function, prevent complications and ensure continence. The need to achieve bladder emptying at low pressure without relying on an indwelling catheter has been known for years. The uretero-ileostomy was described by Bricker in 1950 and has been used very often. We report the case of a patient with C6 tetraplegia ASIA A who began to suffer repeated bouts of dysreflexia due to accumulation of detritus and clots in the excluded bladder which required a radical cystectomy to resolve the problem 20 years after a Bricker's uretero-ileostomy (AU)

Oxycodone improves pain control and quality of life in anticonvulsant-pretreated spinal cord-injured patients with neuropathic pain.

STUDY DESIGN: A 3-month follow-up, observational, prospective, multicenter, study in traumatic spinal cord-injured (SCI) patients with neuropathic pain (NP). OBJECTIVES: To assess the effectiveness and safety of oxycodone treatment in SCI patients with anticonvulsants-refractory NP. SETTING: 'Spinal injury follow-up units' throughout Spain. METHODS: Data regarding NP characteristics were collated from male and female adults with traumatic SCI and difficult-to-control central NP of moderate-to-severe intensity (visual analog scale (VAS) ≥4) persisting ≥1 month, who had been para- or tetraplegic for ≥2 months, had been previously treated with anticonvulsants and were now treated with oxycodone. RESULTS: In all, 54 out of the 57 patients recruited were assessable. A total of 81% were men and the mean age was 46.4. Patients were treated with oxycodone, 83% combined with anticonvulsant. Pain intensity (VAS: 7.1 ± 1.3-4.3 ± 1.7) and Lattinen total score (13.2 ± 3-7.7 ± 3.4) decreased significantly (P < 0.001) along the study. No patient got worse regarding pain impact on physical activity and on sleep (Lattinen scale). EQ-5D VAS showed a trend to increase (P = 0.061) and the index of preference values increased significantly from baseline to month 3 (0.26-0.62; P < 0.001). A total of 53.7% patients showed at least one treatment-related adverse event, with constipation being the most frequent one (33.3%). CONCLUSION: Oxycodone treatment, mostly in combination with anticonvulsants, in SCI patients with NP decreases pain intensity, improves health-related quality of life and diminishes the impact of pain on physical activity and sleep.

[Do the incontinent patients improve their equality of life using a humidity detector device?]. / Mejora un detector de humedad la calidad de vida de los pacientes con incontinencia urinaria?: un estudio piloto.

BACKGROUND: To evaluate the effect of a humidity detector device on the quality of life of patients with urinary incontinence IU. METHOD: Quasi-experimental study: a series of ten cases followed for a month. The devices were placed and the questionnaires filled in before and after using it for at least ten hours a day during a month. Health related quality of life was assessed through the questionnaires for IU convalidated and adapted to our specific environment: Urogenital Inventory Distress (UDI) and Incontinence Impact Questionary (IIQ). An improvement of 58 points by a four option Likert scale was considered a positive impact in the quality of life (IIQ). The scores obtained in UDI and IIQ are described before and after use the device and paried T test and Wilcoxon sign test were carried out to compare the scores obtained in each instance. The capacity to detect a difference of 58 points on the UDI scale was calculated (minimum relevant difference). A binomial test was undertaken to ascertain a probability of achieving an increase in the above mentioned index which would exceed the clinical relevance threshold. RESULTS: Average increase in IIQ improvement: x = 5.48 (Std Error = 20.43) 95% CI = -34.56 to 45.56. Average increase in UDI improvement: x = -11.87 (Std Error = 20.70) 95% IC = -52.45 to 28.70. The power of the analysis to detect as relevant a difference of a 588 point increase in IIQ 71.1% and probability of obtaining a relevant improvement in the questionnaire IIQ 10% (IC 95%) 0% to 39.4%. CONCLUSIONS: A negative impact in the Quality of Life due to frequent changes of incontinence pads.